{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-005654","form_type":"8-K","ticker":"CALC","cik":"0001534133","company_name":"CalciMedica, Inc.","filed_at":"2025-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.922257+00:00","generated_at":"2026-05-28T01:58:10.195124+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"CalciMedica director Eric Bjerkholt resigns; Alan Glicklich appointed to board","bullets":["Eric Bjerkholt resigned as director and audit committee chair effective Jan 15, 2025; no disagreement with company.","Board appointed Alan Glicklich, M.D. as Class I director effective same date, term expires at 2027 annual meeting.","Dr. Glicklich receives $40,000 annual cash retainer (pro-rated) and option for 20,000 shares vesting over three years.","No arrangements or transactions requiring disclosure under Item 404(a) between Dr. Glicklich and company."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-005654","json":"https://secwatch.observer/filing/0001193125-25-005654.json","markdown":"https://secwatch.observer/filing/0001193125-25-005654.md","text":"https://secwatch.observer/filing/0001193125-25-005654.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534133/000119312525005654/0001193125-25-005654-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534133/000119312525005654/d902412d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T01:58:10.195124+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f8d2d719f1","claim":"Alan Glicklich was appointed as Class I Director at CalciMedica, Inc..","evidence_excerpt":"On January 13, 2025, the Company’s Board appointed Alan Glicklich, M.D., as a Class I director of the Company, effective as of the Effective Date, with a term of office expiring at the 2027 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534133/000119312525005654/0001193125-25-005654-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"},{"claim_id":"fc5f8f6b2a","claim":"Eric Bjerkholt resigned as Director and Chair of Audit Committee at CalciMedica, Inc..","evidence_excerpt":"On January 10, 2025, Eric Bjerkholt tendered his resignation as a member of the board of directors (the “Board”) of CalciMedica, Inc., a Delaware corporation (the “Company”) and as Chair and a member of the audit committee of the Board, effective as of January 15, 2025 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534133/000119312525005654/0001193125-25-005654-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director and Chair of Audit Committee"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}